Skip to content

Supplier News

Percodan generic released by Mylan

Mylan Inc. has launched oxycodone and aspirin tablets, a treatment for moderate to severe pain. The company said Thursday that the product, oxycodone and Aspirin Tablets 4.8355 mg/325 mg, were launched by its Mylan Pharmaceuticals Inc.

P&G reorganizes beauty and grooming, household care units

Procter & Gamble Co. has announced a leadership change in and realignment of its beauty and grooming division and household care unit. P&G said Wednesday that Edward Shirley, vice chairman of beauty and grooming, will retire from the company on Jan. 1, 2012, after 33 years service.

Perrigo gets FDA OK for generic Rogaine foam

Perrigo Co. has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter minoxidil foam, a generic version of Men’s Rogaine Foam. Perrigo said Monday that it had been sued for patent infringement by Stiefel Research Australia Pty.

La Roche-Posay kicks off ‘SOS – Save Our Skin’ campaign

La Roche-Posay has launched its second "SOS – Save Our Skin" campaign, which aims to inform Americans about the dangers of ultraviolet rays and the importance of sun safety and get them to take action. The company said Monday that in its first year, the SOS – Save Our Skin online campaign

Teva to buy Cephalon

Teva Pharmaceutical Industries Ltd. plans to acquire Cephalon Inc. in a $6.8 billion cash deal. The pharmaceutical companies said Monday that the $81.50-per-share acquisition agreement, pending regulatory and shareholder approvals, is expected to close in the third quarter.

Leo Pharma enhances Taclonex website

Leo Pharma Inc. has gone live with an expanded website for its Taclonex topical medications for psoriasis. The company said Thursday that updates to the www.taclonex.com site include the addition of product information for both Taclonex Ointment (calcipotriene 0.